EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Analysis of the 5xFAD Mouse Model of Alzheimer’s Disease Using dMRI, Immunohistochemistry, and Neuronal and Glial Functional Metabolic Mapping

Emil W Westi iD, Saba Molhemi iD, Caroline Termøhlen Hansen, Christian Stald Skoven iD, Rasmus West Knopper iD, Dashne Amein Ahmad iD, Maja B Rindshøj, Aishat O Ameen, Brian Hansen, Kristi A Kohlmeier iD, Blanca I Aldana

Biomolecules · 13.10.2024 · 14 (10) · 1294

DOI: 10.3390/biom14101294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 13.10.2024. Verfasst von Emil W Westi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark. Hauptthemen laut MEDLINE: Alzheimer Disease, Disease Models, Animal, Mice, Transgenic, Immunohistochemistry. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Independent Research Fund Denmark, Lundbeck Foundation, Neuroscience Academy Denmark, Lundbeck Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is characterized by complex interactions between neuropathological markers, metabolic dysregulation, and structural brain changes. In this study, we utilized a multimodal approach, combining immunohistochemistry, functional metabolic mapping, and microstructure sensitive diffusion MRI (dMRI) to progressively investigate these interactions in the 5xFAD mouse model of AD. Our analysis revealed age-dependent and region-specific accumulation of key AD markers, including amyloid-beta (Aβ), GFAP, and IBA1, with significant differences observed between the hippocampal formation and upper and lower regions of the cortex by 6 months of age. Functional metabolic mapping validated localized disruptions in energy metabolism, with glucose hypometabolism in the hippocampus and impaired astrocytic metabolism in the cortex. Notably, increased cortical glutaminolysis suggested a shift in microglial metabolism, reflecting an adaptive response to neuroinflammatory processes. While dMRI showed no significant microstructural differences between 5xFAD and wild-type controls, the study highlights the importance of metabolic alterations as critical events in AD pathology. These findings emphasize the need for targeted therapeutic strategies addressing specific metabolic disturbances and underscore the potential of integrating advanced imaging with metabolic and molecular analyses to advance our understanding of AD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDisease Models, AnimalMice, TransgenicImmunohistochemistryAnimalsMiceNeuronsNeurogliaDiffusion Magnetic Resonance ImagingAmyloid beta-PeptidesHippocampusMaleBrainAstrocytesFemale

Stichwörter der Autor:innen

5xFAD mouseAlzheimer’s diseaseamyloid-betaastrocytesdiffusion MRIenergy metabolismgliosismicrogliawhite mater degeneration

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100 Copenhagen, Denmark.
  • Center of Functionally Integrative Neuroscience, Department of Clinical Medicine, Aarhus University, 8000 Aarhus, Denmark.
  • Sino-Danish Center for Education and Research, University of Chinese Academy of Sciences, Beijing 100040, China.

ORCID-Profile: Emil W Westi, Saba Molhemi, Christian Stald Skoven, Rasmus West Knopper, Dashne Amein Ahmad, Kristi A Kohlmeier

Förderung

  • The Independent Research Fund Denmark
  • Lundbeck Foundation, Neuroscience Academy Denmark
  • Lundbeck Foundation
  • Independent Research Fund Denmark

Zitieren

APA

Westi, E. W., Molhemi, S., Hansen, C. T., Skoven, C. S., Knopper, R. W., Ahmad, D. A., Rindshøj, M. B., Ameen, A. O., Hansen, B., Kohlmeier, K. A., & Aldana, B. I. (2024). Comprehensive Analysis of the 5xFAD Mouse Model of Alzheimer’s Disease Using dMRI, Immunohistochemistry, and Neuronal and Glial Functional Metabolic Mapping. Biomolecules, 14(10), 1294. https://doi.org/10.3390/biom14101294

Vancouver

Westi EW, Molhemi S, Hansen CT, Skoven CS, Knopper RW, Ahmad DA, et al. Comprehensive Analysis of the 5xFAD Mouse Model of Alzheimer’s Disease Using dMRI, Immunohistochemistry, and Neuronal and Glial Functional Metabolic Mapping. Biomolecules. 2024;14(10):1294. doi:10.3390/biom14101294

BibTeX
@article{Westi2024,
  author = {Westi, Emil W and Molhemi, Saba and Hansen, Caroline Termøhlen and Skoven, Christian Stald and Knopper, Rasmus West and Ahmad, Dashne Amein and Rindshøj, Maja B and Ameen, Aishat O and Hansen, Brian and Kohlmeier, Kristi A and Aldana, Blanca I},
  title = {Comprehensive Analysis of the 5xFAD Mouse Model of Alzheimer’s Disease Using dMRI, Immunohistochemistry, and Neuronal and Glial Functional Metabolic Mapping},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {10},
  pages = {1294},
  doi = {10.3390/biom14101294}
}
Kostenlos starten →